HSBC Reiterates “€68.00” Price Target for Gerresheimer (GXI)

HSBC set a €68.00 ($79.07) price objective on Gerresheimer (ETR:GXI) in a report released on Wednesday morning. The firm currently has a neutral rating on the stock.

Several other research firms have also recently issued reports on GXI. Berenberg Bank set a €81.00 ($94.19) price objective on shares of Gerresheimer and gave the company a buy rating in a report on Thursday, January 31st. Credit Suisse Group set a €82.00 ($95.35) price objective on shares of Gerresheimer and gave the company a buy rating in a report on Thursday, February 14th. JPMorgan Chase & Co. set a €49.50 ($57.56) price objective on shares of Gerresheimer and gave the company a sell rating in a report on Monday, January 21st. Kepler Capital Markets set a €62.00 ($72.09) price objective on shares of Gerresheimer and gave the company a sell rating in a report on Friday, February 15th. Finally, Deutsche Bank set a €86.00 ($100.00) price objective on shares of Gerresheimer and gave the company a buy rating in a report on Tuesday, January 15th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and four have issued a buy rating to the stock. The stock has an average rating of Hold and an average target price of €68.70 ($79.88).

Gerresheimer stock opened at €69.10 ($80.35) on Wednesday. Gerresheimer has a 12-month low of €59.97 ($69.73) and a 12-month high of €78.25 ($90.99).

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

See Also: How interest rates affect municipal bond prices

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.